PCN94 Cost-Effectiveness of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies fo ...
Abstract
Authors
G. Gourzoulidis M. Koulentaki A. Koumarianou E. Samantas N. Androulakis S. Xynogalos P. Papakotoulas I. Boukovinas M. Karamouzis I. Souglakos V. Chotzagiannoglou A. Beletsi G. Kourlaba